Form 4 for AZTA Azenta, Inc.
Accepted 2026-09-16 20:25:33 ET · period of report 2026-09-14 · accession 0001628280-26-062348 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 20:25 | 2026-09-14 | AZTA | MARTIN WILLIAM E. III | Pres Multiomics | A - Grant | $0.00 | +15.3K | 33.1K | +86% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common | 2026-09-14 | A | A | 15,272 | $0.00 | 33,062 | D | — | — | (F1) Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement. |